How I treat the postthrombotic syndrome
The postthrombotic syndrome (PTS) is a chronic complication of deep vein thrombosis (DVT) that imposes significant morbidity, reduces quality of life, and is costly.
Blood. 2018;131(20):2215-2222
The postthrombotic syndrome (PTS) is a chronic complication of deep vein thrombosis (DVT) that imposes significant morbidity, reduces quality of life, and is costly.
Blood. 2018;131(20):2215-2222
Type 2B von Willebrand disease (VWD) is an inherited bleeding disorder caused by changes in von Willebrand factor (VWF) that enhance binding of VWF to GPIb on platelets.
BLOOD, 22 MARCH 2018 | VOLUME 131, NUMBER 12
Disseminated intravascular coagulation (DIC) is a condition characterized by systemic activation of coagulation, potentially leading to thrombotic obstruction of small and midsize vessels, thereby contributing to organ dysfunction.
BLOOD, 22 FEBRUARY 2018 | VOLUME 131, NUMBER 8
The incidence of pediatric venous thromboembolism (VTE) has been increasing significantly over the past decade in part as a result of increased recognition of this serious disorder but more so because of the increased use of central venous
catheters and other technological advancements involved in the care of ill children.
Blood. 2017;130(12):1402-1408
מתי נחשוד ב: antiphospholipid syndrome) APS)
Blood. 2016;128(3):348-359
Situations that ordinarily necessitate consideration of anticoagulation, such as arterial and venous thrombotic events and prevention of stroke in atrial fibrillation, become challenging in patients with inherited bleeding disorders such as hemophilia A, hemophilia B, and von Willebrand disease.
BLOOD, 14 JULY 2016 x VOLUME 128, NUMBER 2
Deep-vein thrombosis (DVT) is regarded a chronic disease as it often recurs. DVT affects most frequently the lower limbs and hence DVT of the leg will be the focus of this article.
Blood. 2016;127(6):696-702
Blood. 2015;126(11):1285-1293
Acquired thrombotic thrombocytopenic purpura (TTP) is characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) without an obvious
cause, and may include fever, mild renal failure, and neurologic deficits.
BLOOD, 18 JUNE 2015 x VOLUME 125, NUMBER 25
נותנות החסות לאיגוד: